US Patent 6,436,991 dated August 20, 2002, granted to Sabinsa Corporation, covers the antioxidant and cancer chemopreventive roles of constituents of Gugulipid®, the Commiphora mukul extract composition from Sabinsa Corporation. This invention, titled "Compositions for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease", further unravels the multifaceted healthful benefits of this increasingly popular phytonutrient.
Gugulipid® : Patent issued for Chemopreventive and Anti-inflammatory roles
